Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) Research & Development: 2018-2024

Historic Research & Development for Gossamer Bio (GOSS) over the last 7 years, with Dec 2024 value amounting to $138.5 million.

  • Gossamer Bio's Research & Development rose 30.50% to $45.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $161.3 million, marking a year-over-year increase of 21.86%. This contributed to the annual value of $138.5 million for FY2024, which is 2.35% up from last year.
  • According to the latest figures from FY2024, Gossamer Bio's Research & Development is $138.5 million, which was up 2.35% from $135.3 million recorded in FY2023.
  • In the past 5 years, Gossamer Bio's Research & Development registered a high of $170.9 million during FY2022, and its lowest value of $135.3 million during FY2023.
  • For the 3-year period, Gossamer Bio's Research & Development averaged around $148.2 million, with its median value being $138.5 million (2024).
  • Per our database at Business Quant, Gossamer Bio's Research & Development rose by 12.17% in 2020 and then fell by 20.84% in 2023.
  • Yearly analysis of 5 years shows Gossamer Bio's Research & Development stood at $160.9 million in 2020, then rose by 5.85% to $170.3 million in 2021, then grew by 0.38% to $170.9 million in 2022, then declined by 20.84% to $135.3 million in 2023, then increased by 2.35% to $138.5 million in 2024.